8-98089695-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_173549.3(ERICH5):āc.678A>Cā(p.Glu226Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00102 in 1,614,186 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_173549.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000637 AC: 97AN: 152242Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000704 AC: 176AN: 250050Hom.: 1 AF XY: 0.000738 AC XY: 100AN XY: 135486
GnomAD4 exome AF: 0.00106 AC: 1556AN: 1461826Hom.: 3 Cov.: 32 AF XY: 0.00105 AC XY: 760AN XY: 727212
GnomAD4 genome AF: 0.000637 AC: 97AN: 152360Hom.: 0 Cov.: 33 AF XY: 0.000510 AC XY: 38AN XY: 74510
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.678A>C (p.E226D) alteration is located in exon 2 (coding exon 2) of the ERICH5 gene. This alteration results from a A to C substitution at nucleotide position 678, causing the glutamic acid (E) at amino acid position 226 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at